AKEBIA THERAPEUTICS, INC. Inventory Write-down
AKEBIA THERAPEUTICS, INC. (AKBA) reported Inventory Write-down of $4.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-05
- AKEBIA THERAPEUTICS, INC. inventory write-down for the quarter ending 2026-06-30 was $1.73M.
- AKEBIA THERAPEUTICS, INC. inventory write-down for the quarter ending 2026-03-31 was $3.22M, a 1873.01% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. inventory write-down for the quarter ending 2025-12-31 was $1.86M, a 3.05% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. inventory write-down for the quarter ending 2025-09-30 was $530.00K, a 60.51% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. inventory write-down for fiscal 2025 was $2.50M, a 40.47% decline from fiscal 2024.
- AKEBIA THERAPEUTICS, INC. inventory write-down for fiscal 2024 was $4.21M, a 166.33% increase from fiscal 2023.
- AKEBIA THERAPEUTICS, INC. inventory write-down for fiscal 2023 was $1.58M, a 94.77% decline from fiscal 2022.
- AKEBIA THERAPEUTICS, INC. inventory write-down for fiscal 2022 was $30.20M, a 100.68% increase from fiscal 2021.
| Period end | Inventory Write-down 1 month | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.94M 10-Q · filed 2026-08-05 | $6.80M derived: sum of 3 quarters · filed 2026-08-05 | $7.33M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $3.22M 10-Q · filed 2026-05-07 | $5.08M derived: sum of 2 quarters · filed 2026-05-07 | $5.61M derived: sum of 3 quarters · filed 2026-05-07 | $5.56M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.39M derived: sum of 2 quarters · filed 2026-02-26 | $2.34M derived: sum of 3 quarters · filed 2026-08-05 | $2.50M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $530.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $482.00K derived: sum of 2 quarters · filed 2026-08-05 | $645.00K 10-Q · filed 2025-11-10 | $2.45M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | -$48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $115.00K 10-Q · filed 2026-08-05 | $1.92M derived: sum of 3 quarters · filed 2026-08-05 | $3.26M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $163.00K 10-Q · filed 2026-05-07 | $1.97M derived: sum of 2 quarters · filed 2026-05-07 | $3.31M derived: sum of 3 quarters · filed 2026-05-07 | $3.78M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.15M derived: sum of 2 quarters · filed 2026-02-26 | $3.62M derived: sum of 3 quarters · filed 2026-02-26 | $4.21M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.81M derived: sum of 2 quarters · filed 2025-11-10 | $2.40M 10-Q · filed 2025-11-10 | $2.66M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $471.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.06M 10-Q · filed 2025-08-07 | $1.31M derived: sum of 3 quarters · filed 2026-02-26 | $2.01M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $590.00K 10-Q · filed 2025-05-08 | $843.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.54M derived: sum of 3 quarters · filed 2026-02-26 | $1.84M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $953.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.25M derived: sum of 3 quarters · filed 2026-02-26 | $1.58M 10-K · filed 2026-02-26 | $1.60M 10-K · filed 2024-03-14 | |
| 2023-09-30 | $700.00K 10-Q · filed 2023-11-08 | $1.00M derived: sum of 2 quarters · filed 2023-11-08 | $1.33M 10-Q · filed 2024-11-07 | $21.53M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2023-06-30 | $300.00K 10-Q · filed 2023-08-28 | $612.00K 10-Q · filed 2024-08-08 | $20.83M derived: sum of 3 quarters · filed 2024-05-09 | $23.43M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2023-03-31 | $335.00K 10-Q · filed 2024-05-09 | $20.53M derived: sum of 2 quarters · filed 2024-05-09 | $23.13M derived: sum of 3 quarters · filed 2024-05-09 | $25.23M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $20.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $22.80M derived: sum of 2 quarters · filed 2024-03-14 | $24.90M derived: sum of 3 quarters · filed 2024-03-14 | $30.20M 10-K · filed 2024-03-14 | $30.24M 10-K · filed 2023-03-10 | |
| 2022-09-30 | $2.60M 10-Q · filed 2023-11-08 | $4.70M derived: sum of 2 quarters · filed 2023-11-08 | $10.00M 10-Q · filed 2023-11-08 | $17.97M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $2.10M 10-Q · filed 2023-08-28 | $7.43M 10-Q · filed 2023-08-28 | $15.37M derived: sum of 3 quarters · filed 2023-08-28 | $17.07M derived: sum of 4 quarters · filed 2023-08-28 | ||
| 2022-03-31 | $5.34M 10-Q · filed 2023-05-08 | $13.27M derived: sum of 2 quarters · filed 2023-08-28 | $14.97M derived: sum of 3 quarters · filed 2023-08-28 | $15.37M derived: sum of 4 quarters · filed 2023-08-28 | ||
| 2021-12-31 | $7.92M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | $9.62M derived: sum of 2 quarters · filed 2023-08-28 | $10.02M derived: sum of 3 quarters · filed 2023-08-28 | $15.05M 10-K/A · filed 2023-08-28 | $15.62M 10-K · filed 2022-03-01 | |
| 2021-09-30 | $1.70M 10-Q · filed 2022-11-03 | $2.10M derived: sum of 2 quarters · filed 2022-11-03 | $7.13M 10-Q · filed 2022-11-03 | $9.21M derived: sum of 4 quarters · filed 2023-08-28 | ||
| 2021-06-30 | $400.00K 10-Q · filed 2022-08-04 | $5.42M 10-Q · filed 2022-08-04 | $7.51M derived: sum of 3 quarters · filed 2023-08-28 | $16.01M derived: sum of 4 quarters · filed 2023-08-28 | ||
| 2021-03-31 | $5.08M 10-Q · filed 2022-05-09 | $7.11M derived: sum of 2 quarters · filed 2023-08-28 | $15.61M derived: sum of 3 quarters · filed 2023-08-28 | $25.51M derived: sum of 4 quarters · filed 2023-08-28 | ||
| 2020-12-31 | $2.03M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | $10.53M derived: sum of 2 quarters · filed 2023-08-28 | $20.43M derived: sum of 3 quarters · filed 2023-08-28 | $20.64M 10-K/A · filed 2023-08-28 | $20.07M 10-K · filed 2021-02-25 | |
| 2020-09-30 | $8.50M 10-Q · filed 2021-11-04 | $18.40M derived: sum of 2 quarters · filed 2021-11-04 | $18.61M 10-Q · filed 2021-11-04 | $19.68M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $9.90M 10-Q · filed 2021-08-05 | $10.09M 10-Q · filed 2021-08-05 | $11.18M derived: sum of 3 quarters · filed 2022-03-01 | $14.08M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $139.00K 10-Q · filed 2021-05-10 | $1.28M derived: sum of 2 quarters · filed 2022-03-01 | $4.18M derived: sum of 3 quarters · filed 2022-03-01 | $5.48M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.04M derived: sum of 2 quarters · filed 2022-03-01 | $5.34M derived: sum of 3 quarters · filed 2022-03-01 | $7.11M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $2.90M 10-Q · filed 2020-11-05 | $4.20M derived: sum of 2 quarters · filed 2020-11-05 | $5.97M 10-Q · filed 2020-11-05 | $5.86M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-06-30 | $1.30M 10-Q · filed 2020-08-10 | $3.02M 10-Q · filed 2020-08-10 | $2.96M derived: sum of 3 quarters · filed 2021-02-25 | $2.96M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-03-31 | $1.66M 10-Q · filed 2020-05-05 | $1.66M derived: sum of 2 quarters · filed 2021-02-25 | $1.66M derived: sum of 3 quarters · filed 2021-02-25 | $1.66M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |